comparemela.com

Latest Breaking News On - Medexus pharmaceuticals - Page 1 : comparemela.com

Short Interest in Medexus Pharmaceuticals Inc (OTCMKTS:MEDXF) Expands By 26 9%

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 151,400 shares, a growth of 26.9% from the April 30th total of 119,300 shares. Based on an average trading volume of 13,300 shares, the days-to-cover ratio is presently 11.4 […]

United statesMedexus pharmaceuticals price performanceMedexus pharmaceuticalsMedexus pharmaceuticals incNews ratings for medexus pharmaceuticals dailyGet free reportPharmaceuticals incMedexus pharmaceuticals daily

Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading 1 7% Higher

Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded up 1.7% on Tuesday . The stock traded as high as $1.20 and last traded at $1.19. 10,036 shares were traded during trading, a decline of 44% from the average session volume of 17,766 shares. The stock had previously closed at $1.17. Medexus Pharmaceuticals […]

United statesMedexus pharmaceuticalsNews ratings for medexus pharmaceuticals dailyMedexus pharmaceuticals company profileMedexus pharmaceuticals incMedexus pharmaceuticals trading downGet free reportPharmaceuticals trading downPharmaceuticals incMedexus pharmaceuticals daily

Stem Cell Collaboration, R&D, and Licensing Deals Analysis

Dublin, May 07, 2024 (GLOBE NEWSWIRE) The

Columbia universityNew yorkUnited statesSalk instituteUniversity of southern californiaUniversity of california san franciscoNational institutes of healthAbu dhabiAbuz abyUnited arab emiratesUniversity of california los angelesJohns hopkins universityStanford universityCity ofUnited kingdomHarvard university

Medexus Pharmaceuticals Accepts Metoject® Ruling

Medexus Pharmaceuticals (TSE:MDP) has released an update. Medexus Pharmaceuticals has announced that it will not appeal the Federal Court’s decisio.

Medexus pharmaceuticalsFederal courtReaking news

Medexus Pharmaceuticals Inc : Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada

Medexus Pharmaceuticals Inc : Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSouth australiaRichard labelleIllinois newsfile corpCanada federal courtMedexus pharmaceuticals incMedexus pharmaceuticalsDecisions of the federal courtFederal courtGeneral manager canadianChief executiveNorth americanCarsten stork

vimarsana © 2020. All Rights Reserved.